5 Best Investment Trusts of 2018

Two Baillie Gifford closed-end funds are the best performing trusts of 2018, while emerging market funds continued to struggle

David Brenchley 20 July, 2018 | 7:26AM
Facebook Twitter LinkedIn

Amazon Prime, Technology stocks, stock market, Amazon share price, Scottish Mortgage, investment trusts

Buoyed by the exceptional performance of large-cap US stocks and tech companies, two Baillie Gifford closed-end funds are the best-performing Morningstar rated investment trusts year to date.

Elsewhere, smaller company offerings performed well, with healthcare and biotech stocks getting a reprieve after a difficult time during the US election campaign back in late 2016.

Latin America-focused trusts were by far the worst performers, with double-digit losses. Emerging market and high-yield offerings also struggled.

Below, we reveal the five best and the five worst performing closed-end funds in the first half of 2018.

5 Best-Performing Trusts

Unsurprisingly, with tech and growth stocks continuing their rally, Scottish Mortgage (SMT) topped of the charts. The £7.8 billion James Anderson-managed offering returned investors a huge 19% in the first half of 2018.

Despite that, some of the Morningstar Gold Rated trust’s biggest holdings – mainly China-focused Alibaba, Tencent and Baidu – either only marginally gained, or lost money in the six months. But Amazon (AMZN), its largest stock at 10% of the portfolio, grew by 50%; Netflix (NFLX) doubled; and Kering (KER) and Ferrari (RACE) both put on a third.

Edinburgh Worldwide’s (EWI) came in a close second, returning 17.7%. The £500 million trust’s performance was boosted by the performance of UK holding Ocado (OCDO), which signed a blockbuster deal with US firm Kroger (KR). Shares have doubled in the past two months.

A pair of smaller companies trusts came next, though a long way behind the leading two. The £725 million Morningstar Gold Rated BlackRock Smaller Companies (BRSC), managed by Mike Prentis, returned 9.2%. Headlined by veterinary services supplier Dechra Pharmaceuticals (DPH) and recruitment firm Robert Walters (RWA), the fund was buoyed by the performance of small UK firms.

Montanaro European Smaller Companies (MTE), a tiny, £150 million, Bronze Rated offering, came in just behind BRSC up 9% in the first half. The trust, run by George Cooke, has a fifth of its assets invested in Swedish companies.

Rounding off the top five is Worldwide Healthcare (WWH), which gained 7.3% as drugmakers’ share prices got some relief from a surprisingly unremarkable speech on drug pricing from US President Donald Trump.

5 Worst-Performing Trusts

As with the list of worst-performing funds, it was emerging market-focused offerings that dominated at the bottom. While the Gold Rated Murray International trust (MYI) has a global mandate, it has a tilt towards emerging countries.

Bruce Stout’s £1.4 billion fund has a quarter of its portfolio in Asia and 15% in Latin America and other emerging markets, meaning performance – a loss of 8.4% in the first six months of the year – was affected by trade war talk.

Similar comments apply to Invesco Asia (IAT), losing 5.8%, and JPMorgan Global Emerging Markets Income (JEMI), down 4.3%. The former has just over a quarter of its portfolio exposed to China, with a further 15% in Hong Kong. The latter is less exposed to China, but has 15% in Brazil and Mexico and 4% in the poorly performing market of India.

The JP Morgan Indian Trust (JII) was the second worst-performing closed-end fund in the half. It avoided last place by 2 basis points, but has struggled as the Indian market continues to underperform due to recent US dollar strength.

Interestingly, despite Russia being one of the better performing stock markets in the year-to-date, BlackRock Emerging Europe (BEEP) also performed poorly, losing 4.63%.

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar
Rating
Amazon.com Inc180.75 USD-0.17Rating
BlackRock Smaller Companies Ord1,490.00 GBX0.00Rating
Dechra Pharmaceuticals PLC3,822.00 GBP0.00
Edinburgh Worldwide Ord143.40 GBX-0.28Rating
Ferrari NV416.16 USD0.64Rating
Invesco Asia Ord328.00 GBX0.00Rating
JPMorgan Global Emerg Mkts Inc Ord136.00 GBX-0.73Rating
JPMorgan Indian Ord962.00 GBX1.48Rating
Montanaro European Smaller Ord143.50 GBX-0.69Rating
Murray International Ord252.00 GBX0.00Rating
Netflix Inc646.75 USD1.74Rating
Ocado Group PLC373.80 GBX6.16Rating
Robert Walters PLC407.00 GBX0.25
Scottish Mortgage Ord901.00 GBX0.11Rating
The Kroger Co52.99 USD-0.60Rating
Worldwide Healthcare Ord347.50 GBX0.00Rating

About Author

David Brenchley

David Brenchley  is a Reporter for Morningstar.co.uk

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures